PC
QTTB icon

PA Capital’s Q32 Bio QTTB Stock Holding History

PA Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,180
Closed -$416K – 137
2019
Q2 		$416K Buy
+1,180
New +$464K 0.38% 80

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PA Capital's QTTB Position: Q3 2019 in Review

PA Capital sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 1,180 shares — an estimated $416K sold.

PA Capital first reported a position in QTTB in Q2 2019 and held it in 1 quarter. The position peaked at $416K in Q2 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • PA Capital reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
  • PA Capital sold 1,180 Q32 Bio shares in Q3 2019, an estimated $416K.
  • PA Capital first reported a position in Q32 Bio in Q2 2019 and held it in 1 quarter.
  • PA Capital's Q32 Bio position peaked at $416K in Q2 2019.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on PA Capital's 13F filing for Q3 2019, filed 8 Nov 2019.